BackOruka Therapeutics Overview
Oruka Therapeutics, Inc.

Oruka Therapeutics Discounted Cash Flow

DCF Analysis for ORKA.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.99

Current Fair Value

$0.99
98.6% Downside

Overvalued by 98.6% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading